Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Tumors
FDG-PET used to detect bone tumors when bone scintigraphy gave negative findings
February 14th, 2006
Positron emission tomography (PET) with 18-F-fluorodeaxyglucose (FDG) can be used to detect bony metastases of esophageal carcinomas when scintigraphy fails. "FDG-PET has already proved useful in assessing the extension of esophageal carcinomas, detecting tumor recurrence and monitoring responses to therapy. This study aimed to elucidate the potential role of FDG-PET compared with technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy in the evaluation of bony metastasis in esophageal carcinoma patients," investigators in Japan reported. "Forty-four patients with thoracic esophageal carcinomas, who underwent FDG-PET together with bone...
Source: Cancer Weekly (2006-02-14)
|
